Benefits
Traditionally used to soothe dry, irritating cough
European regulators register ribwort plantain leaf as a traditional herbal medicine to soothe mouth or throat irritation with an associated dry cough, and to relieve cough during a cold. That status rests on at least 30 years of documented use, not on trial results; the assessors declined the higher evidence tier because controlled studies of the leaf have never been done.
Demulcent mucilage for throat comfort
The dried leaf contains roughly 2 to 6.5 percent mucilage, water-binding sugars that are not absorbed and are thought to lay a protective film over irritated mucous membranes. In a tissue test on pig cheek lining, plantain polysaccharides adhered only moderately, less than calendula or bladderwrack. A coating effect on the throat is plausible, but nobody has measured it in people.
Cough scores fell in an uncontrolled syrup study
In a post-marketing study of an alcohol-based plantain syrup, summarized by the EU herbal committee, 593 people, mostly with acute respiratory infections, acute bronchitis or lingering irritative cough reported cough intensity down about 67 percent after 3 to 14 days. There was no placebo group, and such coughs usually ease on their own over that span, so the figure cannot be credited to the herb.
An ingredient in multi-herb cough syrups for children
Two small placebo-controlled trials in children tested honey syrups combining plantain with other herbs. A four-herb syrup in ages 5 to 11 lowered daytime cough scores versus placebo from day three and night scores from day four; a three-herb syrup in ages 3 to 6 beat placebo only on night cough at day four. The makers sponsored or supplied both, and neither can credit plantain. European guidance advises against oral use under age 3.
Airway muscle relaxation and anti-inflammatory activity in lab studies
In tissue-bath work the extract relaxed guinea pig windpipe and gut muscle, with luteolin and acteoside among the active constituents. In cell-free and animal tests it partly inhibited the inflammatory enzyme COX-2 and trimmed rat paw swelling by about 11 percent, against 45 percent for indomethacin. EU assessors noted the concentrations were high and that clinical relevance cannot be estimated.
Mechanism of action
Mucilage film on the mucous membranes
Plantain mucilage is built mainly from arabinose and galactose-rich polysaccharides that swell with water, are not absorbed, and are thought to cover the mucosa with a protective layer against local irritation. That physical film, rather than any absorbed compound, is the proposed basis for the demulcent claim.
Antispasmodic phenolics: acteoside and luteolin
An ethanolic extract of the aerial parts inhibited contractions of isolated guinea pig ileum triggered by acetylcholine, histamine, potassium and barium, and also barium-induced tracheal contractions. Luteolin and acteoside relaxed tracheal tissue, whereas aucubin and catalpol did not relax the gut strip.
Modest anti-inflammatory activity in models
A freeze-dried ethanol extract inhibited COX-2 by 37 to 58 percent at high concentrations in a cell-free assay while sparing 5-lipoxygenase, and an oral extract cut carrageenan paw swelling in rats by 11 percent. Isolated acteoside, plantamajoside and aucubin were anti-inflammatory in mouse models.
Iridoids aucubin and catalpol, with poor oral uptake
The leaf holds about 2 to 3 percent iridoid glycosides, up to 9 percent in young leaves, mainly aucubin and catalpol. In rats only about 19 percent of oral aucubin reached the circulation, and it breaks down within hours in stomach-strength acid. EU assessors could not name any constituent with known therapeutic activity.
Clinical trials
Pilot randomized, double-blind, placebo-controlled multicenter trial of Sediflù, a eucalyptus honey syrup with dry extracts of plantain leaf, ivy leaf, sundew and horehound (Núñez C, Chiatti MC, Tansella F, Coronel-Rodríguez C, Risco E 2024, Clin Pediatr (Phila) 63(11):1510-1519, PMID 38323572). It did not test plantain on its own.
56 children aged 5 to 11 with a dry or productive cough, 27 on the syrup and 29 on placebo, 10 ml twice daily for 7 days, recruited in two Madrid primary care practices.
Within the syrup group, cough scores fell from day 2. Against placebo, daytime scores were lower from day 3 and night-time scores from day 4, both about 71 percent lower by day 7, and no adverse effects were seen in either group. The manufacturer, Cinfa Laboratories, sponsored the trial and two authors had advised the company. With four herbal extracts plus honey in one product, no share of the effect can be assigned to plantain.
Randomized, double-blind, placebo-controlled multicenter trial of Grintuss pediatric syrup, a medical device made from fractions of Grindelia robusta, Plantago lanceolata, Helichrysum italicum and honey (Canciani M, Murgia V, Caimmi D, Anapurapu S, Licari A, Marseglia GL 2014, Ital J Pediatr 40:56, PMID 24917119). It did not test plantain on its own.
102 children aged 3 to 6 with cough lasting 7 days to 3 weeks, 51 per group (91 completed), 5 ml four times daily for 8 days, at pediatric units in Udine and Pavia, Italy.
Against placebo, only the night-time cough score at day 4 differed (p = 0.03); other gains were reported within the syrup group, plus a subgroup with stronger daytime cough in which 13 of 14 children improved on the syrup versus 7 of 13 on placebo. Adverse events hit 17 children in each arm, all judged unrelated. Aboca supplied the syrup and placebo, and one author had advised Aboca among other firms.
Randomized controlled trial of a mouth rinse made from a Plantago lanceolata leaf and flower infusion, used for seven days, alongside laboratory antimicrobial testing (Ferrazzano GF, Cantile T, Roberto L, Ingenito A, Catania MR, Roscetto E, Palumbo G, Zarrelli A, Pollio A 2015, Biomed Res Int 2015:286817, PMID 25767805).
44 adolescents aged 12 to 18 enrolled at a Naples pediatric dentistry department; 40 completed, 20 per group, against a coloured water placebo rinse.
Salivary streptococci fell significantly on the plantain rinse compared with placebo, while lactobacilli counts did not differ between groups. This is the only controlled human study of ribwort plantain on its own identified for this page, and it measured mouth bacteria, not cough or airway symptoms.
German-language narrative review of ribwort plantain for upper respiratory tract infections (Wegener T, Kraft K 1999, Wien Med Wochenschr 149(8-10):211-6, PMID 10483683).
No new participants; summarizes the clinical and laboratory literature available at the time.
The authors wrote that only few clinical data are available and that the anti-inflammatory, antispasmodic and immune-stimulating actions come from experimental research. They still recommended plantain for moderate chronic irritative cough, including in children, on benefit-risk grounds. The lead author's affiliation was a phytopharmaceutical services firm.
Review by the Nutraceutical and Medical Device Task Force of the Italian Society of Pediatric Allergy and Immunology of natural cough products sold in Italy, including ones containing Plantago lanceolata (Ciprandi G, SIAIP Task Force 2025, Minerva Pediatr (Torino), online ahead of print, PMID 40512457).
Children and adolescents with acute post-viral cough; no new participants.
The task force concluded that few clinical studies exist for these products and that the evidence is generally scarce and of poor quality. It advised doctors to know each product's exact composition, literature, dosing and safety before recommending one, and noted that peripheral antitussive drugs are effective and safe.